MICHIKO NAKAMURA
Papers
1
Total Citations
2
H-Index
1
About
Dr. Michiko Nakamura is a leading urological oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the identification of predictive biomarkers for treatment response. Her major contribution centers on the clinical significance of histopathological patterns in prostate cancer, most notably her work demonstrating that the cribriform pattern is a predictive factor for prostate-specific antigen (PSA) recurrence in patients receiving salvage radiotherapy after prostatectomy. This finding, published in 2024, provides clinicians with a critical tool for risk stratification, enabling more personalized post-surgical management. With her work already garnering citations, Dr. Nakamura is establishing herself as a key voice in the intersection of surgical pathology and radiation oncology. Her research addresses a pressing clinical challenge—PSA recurrence after robotic total prostatectomy—and offers actionable insights for treatment planning. By linking specific morphological features to therapeutic outcomes, she is helping to refine salvage radiotherapy protocols and improve long-term prognosis for prostate cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1